PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
5.22
-0.14 (-2.61%)
At close: Sep 25, 2026, 4:00 PM EDT
5.32
+0.10 (1.92%)
After-hours: Sep 25, 2026, 7:30 PM EDT
PolyPid Market Cap
PolyPid has a market cap or net worth of $106.03 million as of September 25, 2026. Its market cap has increased by 93.32% in one year.
Market Cap
106.03M
Enterprise Value
101.04M
1-Year Change
93.32%
Ranking
Category
Stock Price
$5.22
ChartMarket Cap Chart
Since June 26, 2020, PolyPid's market cap has increased from $82.43M to $106.03M, an increase of 28.62%. That is a compound annual growth rate of 4.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 106.03M | 46.86% |
| Dec 31, 2025 | 72.19M | 249.06% |
| Dec 31, 2024 | 20.68M | 229.16% |
| Dec 29, 2023 | 6.28M | -54.17% |
| Dec 30, 2022 | 13.71M | -87.27% |
| Dec 31, 2021 | 107.66M | -41.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cibus | 115.41M |
| Aardvark Therapeutics | 115.00M |
| Vivani Medical | 112.30M |
| Genelux | 110.24M |
| Milestone Pharmaceuticals | 108.78M |
| Black Diamond Therapeutics | 108.01M |
| Equillium | 107.16M |
| Rani Therapeutics Holdings | 106.30M |